ARTICLEhttps://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p222.xmlTaxanes in the Adjuvant Treatment of Breast Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p222.pdf2026-04-18Taxanes in the Adjuvant Treatment of Breast Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p199.xmlPoint: Sentinel Lymph Node Biopsy Is Indicated for Patients With DCIS2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p199.pdf2026-04-18Point: Sentinel Lymph Node Biopsy Is Indicated for Patients With DCIShttps://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p207.xmlCounterpoint: Sentinel Lymph Node Biopsy Is Not Indicated for Ductal Carcinoma In Situ2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p207.pdf2026-04-18Counterpoint: Sentinel Lymph Node Biopsy Is Not Indicated for Ductal Carcinoma In Situhttps://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p215.xmlThe Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p215.pdf2026-04-18The Aromatase Inhibitors as Adjuvant Therapy for Hormone Receptor-Positive Breast Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p189.xmlDecision-Making For Patients With Resectable Breast Cancer: Individualized Decisions For and By Patients and Their Physicians2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p189.pdf2026-04-18Decision-Making For Patients With Resectable Breast Cancer: Individualized Decisions For and By Patients and Their Physicianshttps://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p145.xmlEditorial2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p145.pdf2026-04-18Editorialhttps://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p148.xmlBreast Cancer Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p232.xmlThe Role of Bisphosphonates in Breast Cancer2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p232.pdf2026-04-18The Role of Bisphosphonates in Breast Cancerhttps://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p264.xmlAn Overview of Mammography: Benefits and Limitations2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p264.pdf2026-04-18An Overview of Mammography: Benefits and Limitationshttps://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p272.xmlNew Technologies in Breast Imaging2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p272.pdf2026-04-18New Technologies in Breast Imaginghttps://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p280.xmlBreast Cancer Risk Reduction Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p242.xmlBreast Cancer Screening and Diagnosis Clinical Practice Guidelines in Oncology2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p297.xmlBreast Cancer Risk Assessment: A Guide for Clinicians Using the NCCN Breast Cancer Risk Reduction Guidelines2026-04-18https://harbor.dev.pubfactory.com/view/journals/jnccn/1/2/article-p297.pdf2026-04-18Breast Cancer Risk Assessment: A Guide for Clinicians Using the NCCN Breast Cancer Risk Reduction Guidelines